Wealthcare Advisory Partners’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-4,034
Closed -$714K 1526
2020
Q1
$714K Buy
4,034
+21
+0.5% +$3.95K 0.1% 117
2019
Q4
$767K Buy
4,013
+3,862
+2,558% +$697K 0.1% 125
2019
Q3
$25K Sell
151
-24
-14% -$3.91K ﹤0.01% 697
2019
Q2
$29K Buy
175
+24
+16% +$3.32K ﹤0.01% 637
2019
Q1
$22K Sell
151
-8
-5% -$1.16K ﹤0.01% 644
2018
Q4
$21K Sell
159
-3
-2% -$492 ﹤0.01% 621
2018
Q3
$31K Sell
162
-12
-7% -$2.21K 0.01% 574
2018
Q2
$29K Buy
174
+36
+26% +$5.78K 0.01% 583
2018
Q1
$23K Buy
138
+1
+0.7% +$168 0.01% 557
2017
Q4
$22K Sell
137
-15
-10% -$2.69K 0.01% 525
2017
Q3
$31K Buy
152
+125
+463% +$29.1K 0.01% 367
2017
Q2
$7K Buy
+27
New +$6.34K ﹤0.01% 86

Other funds holding AGN

Wealthcare Advisory Partners's AGN Position: Q2 2020 in Review

Wealthcare Advisory Partners sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 4,034 shares — an estimated $714K sold.

Wealthcare Advisory Partners first reported a position in AGN in Q2 2017 and held it in 12 quarters. The position peaked at $767K in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Wealthcare Advisory Partners reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Wealthcare Advisory Partners sold 4,034 Allergan plc shares in Q2 2020, an estimated $714K.
  • Wealthcare Advisory Partners first reported a position in Allergan plc in Q2 2017 and held it in 12 quarters.
  • Wealthcare Advisory Partners's Allergan plc position peaked at $767K in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Wealthcare Advisory Partners's 13F filing for Q2 2020, filed 29 Jul 2020.